Guest Kevin's most recent trade in Usana Health Sciences Inc was a trade of 31,425 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 31,425 | 75,423 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 7,003 | 28,198 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 7,003 | 48,423 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 4,425 | 43,998 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 4,425 | 29,657 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 2,966 | 25,232 (0%) | 0% | 30.7 | 90,908 | Common Stock |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 1,875 | 27,782 (0%) | 0% | 30.7 | 57,469 | Common Stock |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 12,062 | 22,553 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 12,062 | 62,028 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 6,602 | 23,991 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 6,602 | 55,426 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.21 per share. | 06 Feb 2025 | 5,164 | 17,389 (0%) | 0% | 31.2 | 161,168 | Common Stock |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 06 Feb 2025 | 2,796 | 21,195 (0%) | 0% | 30.6 | 85,697 | Common Stock |
| Usana Health Sciences Inc | Kevin G. Guest | EXEC. CHAIRMAN OF THE BOARD | Sale of securities on an exchange or to another person at price $ 49.00 per share. | 11 Mar 2024 | 11,011 | 10,491 (0%) | 0% | 49 | 539,539 | Common Stock |
| Usana Health Sciences Inc | Guest Kevin | EXECUTIVE CHAIRMAN OF THE BD. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 17,700 | 74,090 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Guest Kevin | EXECUTIVE CHAIRMAN OF THE BD. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 7,004 | 24,469 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Guest Kevin | EXECUTIVE CHAIRMAN OF THE BD. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 7,004 | 56,390 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | EXECUTIVE CHAIRMAN OF THE BD. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.85 per share. | 08 Feb 2024 | 2,967 | 21,502 (0%) | 0% | 50.9 | 150,872 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | EXECUTIVE CHAIRMAN OF THE BD. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 12,061 | 18,768 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Guest Kevin | EXECUTIVE CHAIRMAN OF THE BD. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 12,061 | 69,995 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | EXECUTIVE CHAIRMAN OF THE BD. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 6,601 | 20,261 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Guest Kevin | EXECUTIVE CHAIRMAN OF THE BD. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 6,601 | 63,394 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | EXECUTIVE CHAIRMAN OF THE BD. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.80 per share. | 06 Feb 2024 | 5,108 | 13,660 (0%) | 0% | 47.8 | 244,162 | Common Stock |
| Usana Health Sciences Inc | Guest Kevin | EXECUTIVE CHAIRMAN OF THE BD. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.71 per share. | 06 Feb 2024 | 2,796 | 17,465 (0%) | 0% | 49.7 | 138,989 | Common Stock |
| Usana Health Sciences Inc | Guest Kevin | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 4,596 | 8,654 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Guest Kevin | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 4,596 | 82,056 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Guest Kevin | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.23 per share. | 03 Feb 2024 | 1,947 | 6,707 (0%) | 0% | 47.2 | 91,957 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 07 Mar 2023 | 5,297 | 4,058 (0%) | 0% | 60.2 | 318,636 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 60.28 per share. | 22 Feb 2023 | 13,248 | 9,355 (0%) | 0% | 60.3 | 798,634 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 60.75 per share. | 22 Feb 2023 | 40 | 22,603 (0%) | 0% | 60.8 | 2,430 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 48,245 | 100,257 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 7,003 | 25,609 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 7,003 | 86,652 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 6,602 | 21,402 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 6,602 | 93,655 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.53 per share. | 06 Feb 2023 | 2,966 | 22,643 (0%) | 0% | 61.5 | 182,498 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.76 per share. | 06 Feb 2023 | 2,796 | 18,606 (0%) | 0% | 59.8 | 167,089 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 4,595 | 54,435 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 4,595 | 15,351 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 2,423 | 15,827 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 2,423 | 52,012 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 1,947 | 13,404 (0%) | 0% | 60.0 | 116,898 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 1,027 | 14,800 (0%) | 0% | 60.0 | 61,661 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 26,406 | 66,034 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 7,004 | 59,030 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 7,004 | 13,723 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.30 per share. | 07 Feb 2022 | 2,967 | 10,756 (0%) | 0% | 94.3 | 279,788 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 4,639 | 39,628 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 4,639 | 8,684 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 4,596 | 46,689 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 4,596 | 4,596 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 2,422 | 44,267 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 2,422 | 5,071 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 03 Feb 2022 | 1,965 | 6,719 (0%) | 0% | 92.3 | 181,409 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.82 per share. | 03 Feb 2022 | 1,947 | 2,649 (0%) | 0% | 93.8 | 182,668 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 03 Feb 2022 | 1,026 | 4,045 (0%) | 0% | 92.3 | 94,720 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Sale of securities on an exchange or to another person at price $ 102.35 per share. | 04 Nov 2021 | 1,057 | 0 (0%) | 0% | 102.3 | 108,181 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 1,834 | 51,285 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 1,834 | 1,834 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Sale or transfer of securities back to the company at price $ 99.84 per share. | 23 Oct 2021 | 777 | 1,057 (0%) | 0% | 99.8 | 77,576 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 10,901 | 49,228 | - | - | Stock Settled Stock Appreciation Rights | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 24 Feb 2021 | 8,846 | 550 (0%) | 0% | 95.0 | 840,381 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.02 per share. | 24 Feb 2021 | 3,669 | 13,065 (0%) | 0% | 63.0 | 231,220 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 24 Feb 2021 | 3,669 | 9,396 (0%) | 0% | 95 | 348,555 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 24 Feb 2021 | 550 | 0 (0%) | 0% | 95 | 52,250 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 5,508 | 60,129 | - | - | Stock Settled Stock Appreciation Rights | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.02 per share. | 11 Feb 2021 | 1,854 | 11,250 (0%) | 0% | 63.0 | 116,839 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Sale of securities on an exchange or to another person at price $ 95.35 per share. | 11 Feb 2021 | 1,854 | 9,396 (0%) | 0% | 95.4 | 176,784 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2021 | 28,014 | 53,119 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 1,374 | 25,105 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 1,374 | 9,978 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.20 per share. | 06 Feb 2021 | 582 | 9,396 (0%) | 0% | 84.2 | 49,004 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 4,638 | 26,479 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 4,638 | 10,569 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 4,596 | 5,617 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 4,596 | 35,109 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 2,423 | 6,054 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 2,423 | 32,686 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.76 per share. | 03 Feb 2021 | 1,986 | 3,631 (0%) | 0% | 82.8 | 164,361 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.20 per share. | 03 Feb 2021 | 1,965 | 8,604 (0%) | 0% | 84.2 | 165,453 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,569 | 31,117 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,569 | 6,596 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.18 per share. | 03 Feb 2021 | 1,027 | 5,027 (0%) | 0% | 85.2 | 87,480 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.18 per share. | 03 Feb 2021 | 665 | 5,931 (0%) | 0% | 85.2 | 56,645 | Common Stock |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 1,835 | 39,705 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 1,835 | 3,289 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kevin Guest | C.E.O. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.86 per share. | 23 Oct 2020 | 814 | 2,475 (0%) | 0% | 85.9 | 69,890 | Common Stock |